Cited by 712Venous Thromboembolism Diagnosis and ManagementReproductive Health and ContraceptionBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Open access

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., Agger, C.·2009·BMJ

DOI 10.1136/bmj.b2890PMC PMC2726928

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To assess the risk of venous thrombosis in current users of different types of hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and route of administration. DESIGN: National cohort study. SETTING: Denmark, 1995-2005. PARTICIPANTS: Danish women aged 15-49 with no history of cardiovascular or malignant disease. MAIN OUTCOME MEASURES: Adjusted rate ratios for all first time deep venous thrombosis, portal thrombosis, thrombosis of caval vein, thrombosis of renal vein, unspecified deep vein thrombosis, and pulmonary embolism during the study period. RESULTS: 10.4 million woman years were recorded, 3.3 million woman years in receipt of oral contraceptives. In total, 4213 venous thrombotic events were observed, 2045 in current users of oral contraceptives. The overall absolute risk of venous thrombosis per 10 000 woman years in non-users of oral contraceptives was 3.01 and in current users was 6.29. Compared with non-users of combined oral contraceptives the rate ratio of venous thrombembolism in current users decreased with duration of use (<1 year 4.17, 95% confidence interval 3.73 to 4.66, 1-4 years 2.98, 2.73 to 3.26, and >4 years 2.76, 2.53 to 3.02; P<0.001) and with decreasing dose of oestrogen. Compared with oral contraceptives containing levonorgestrel and with the same dose of oestrogen and length of use, the rate ratio for oral contraceptives with norethisterone was 0.98 (0.71 to 1.37), with norgestimate 1.19 (0.96 to 1.47), with desogestrel 1.82 (1.49 to 2.22), with gestodene 1.86 (1.59 to 2.18), with drospirenone 1.64 (1.27 to 2.10), and with cyproterone 1.88 (1.47 to 2.42). Compared with non-users of oral contraceptives, the rate ratio for venous thromboembolism in users of progestogen only oral contraceptives with levonorgestrel or norethisterone was 0.59 (0.33 to 1.03) or with 75 mug desogestrel was 1.12 (0.36 to 3.49), and for hormone releasing intrauterine devices was 0.90 (0.64 to 1.26). CONCLUSION: The risk of venous thrombosis in current users of combined oral contraceptives decreases with duration of use and decreasing oestrogen dose. For the same dose of oestrogen and the same length of use, oral contraceptives with desogestrel, gestodene, or drospirenone were associated with a significantly higher risk of venous thrombosis than oral contraceptives with levonorgestrel. Progestogen only pills and hormone releasing intrauterine devices were not associated with any increased risk of venous thrombosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.b2890

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 332
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case‐control study
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
Jick, H. (2000) · BMJ · doi:10.1136/bmj.321.7270.1190 · Cited by 193

Flagged first, then by citations

Show all 29 references

Sorted by citations

Items 301–400 of 712

New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control
Nelson, A. L. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s4886 · Cited by 11
Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women
Kobayashi, T., Sugiura, K., & Ojima, T. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13304 · Cited by 11
Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system
Rebelo, R. C., Naseri, E. P., Bahamondes, M. V., Costallat, L. T. L., Appenzeller, S., Bahamondes, L. G., & Fernandes, A. M. D. S. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05131-x · Cited by 11
Thrombophilia
Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M. M., Fletcher, J. M., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840m · Cited by 11
Toward a new concept of “natural balance” in oral estroprogestin contraception
Chabbert‐Buffet, N., Gerris, J., Jamin, C., Lello, S., Lete, I., Lobo, P., Nappi, R. E., & Pintiaux, A. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.824963 · Cited by 11
Communicating risk: does scientific debate compromise safety?
Jensen, J. T., & Trussell, J. (2012) · Contraception · doi:10.1016/j.contraception.2012.06.010 · Cited by 11
FSRH Guideline (August 2022) Progestogen-only Pills
(2022) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2022-pop · Cited by 10
Self‐administration of gender‐affirming hormones and supratherapeutic dosing are relatively common in Japanese transgender women
Baba, T., Endo, T., Ikeda, U., Ikeda, H., Ichihara, K., Masumori, N., & Saito, T. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15231 · Cited by 10
Thrombophilia and hormonal therapy in transgender persons: A literature review and case series
Marianne, K., Vantilborgh, A., Collet, S., & T'Sjoen, G. G. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2025551 · Cited by 10
Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
Prince, M., Glueck, C. J., Shah, P. K., Kumar, A., Goldenberg, M., Rothschild, M., Motayar, N., Jetty, V., Lee, K., & Wang, P. (2016) · BMC Hematology · doi:10.1186/s12878-016-0045-9 · Cited by 10
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report
Zermatten, M. G., Calderara, D. B., Aliotta, A., & Alberio, L. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12318 · Cited by 10
Heme-nitrosylated hemoglobin and oxidative stress in women consuming combined contraceptives. Clinical application of the EPR spectroscopy
Lobysheva, I. I., Eeckhoudt, S. V., Zotti, F. D., Rifahi, A., Pothen, L., Beauloye, C., & Balligand, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.039 · Cited by 10
Observational studies
Herkner, H., & Male, C. (2010) · Springer eBooks · doi:10.1007/978-3-7091-0144-5_9 · Cited by 10
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance
Morimont, L., Donis, N., Bouvy, C., Mullier, F., Dogné, J., & Douxfils, J. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1753511 · Cited by 9
Tailoring Combination Oral Contraceptives to the Individual Woman
Archer, D. F., & Lasa, I. L. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2199 · Cited by 9
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women
Nappi, R. E., Paoletti, A. M., Volpe, A., Chiovato, L., Howard, B. K., Weiss, H., & Ricciotti, N. A. (2014) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2014.918596 · Cited by 9
Risk factors and management of deep venous thrombosis in children following post‐surgical hypopituitarism in craniopharyngioma
Chandrakasan, S., Sood, S., Ham, S. D., Moltz, K. C., Frey, M. J., & Rajpurkar, M. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22937 · Cited by 9
Adolescent girls in Denmark use oral contraceptives at an increasingly young age, and with more pauses and shifts.
Løkkegaard, E., & Nielsen, A. K. (2014) · PubMed · Cited by 9
Menstrual management and reproductive concerns in adolescent and young adult women with underlying hematologic or oncologic disease
Quinn, S. M., & Louis-Jacques, J. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000359 · Cited by 9
Prothrombotic Risk Factors and Preventive Strategies in Adolescent Venous Thromboembolism
Srivaths, L. V., & Dietrich, J. E. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616631428 · Cited by 9
Risk of VTE among users of oral contraceptives
Shapiro, S., & Dinger, J. C. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910791069376 · Cited by 9
Endometrial carcinoma in an asymptomatic patient using the levonorgestrel-releasing intrauterine system
Lee, O.-Y., Shin, Y.-O., Kim, E., & Jeong, E. (2014) · Journal of Biomedical Research · doi:10.12729/jbr.2014.15.4.207 · Cited by 8
Synthetic Hormones and Clot Formation
Swanepoel, A. C., Visagie, A., & Pretorius, E. (2016) · Microscopy and Microanalysis · doi:10.1017/s1431927616011478 · Cited by 8
Influência dos Anticoncepcionais Orais Hormonais na Saúde da Mulher
Guedes, I., Silvério, A. C. K., Santos, R. A. D., & Maia, J. S. (2022) · Revista Brasileira Multidisciplinar · doi:10.25061/2527-2675/rebram/2022.v25i1.995 · Cited by 8
Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
Jørgensen, C. T., Tavoly, M., Førsund, E., Pettersen, H. H., Tjønnfjord, E. B., Ghanima, W., & Brækkan, S. K. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.06.028 · Cited by 8
Documento de consenso sobre tabaquismo y riesgo vascular
Alemán, J. A., Sabarís, R. C., Pardo, D. E., Donaire, J. A. G., Romanos, F. G., Iturralde-Iriso, J., Penagos, L. M., Iglesias, L. J. N., de Salinas, A. P. M., Robles, N. R., et al. (2024) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(24)00075-8 · Cited by 9
The effect of combined oral contraceptives on thrombin generation assessed on ST Genesia– a paired clinical study
Strandberg, J., Gade, I. L., Nybo, J., Thomsen, J. L., & Kristensen, S. R. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00713-z · Cited by 8
Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study
van Vlijmen, E. F. W., Mäkelburg, A. B., Knol, H. M., Tichelaar, V., Kluin‐Nelemans, H. C., Veeger, N. J. G. M., & Meijer, K. (2015) · British Journal of Haematology · doi:10.1111/bjh.13534 · Cited by 8
No effect of Implanon® on inflammatory cardiovascular parameters
Merki‐Feld, G. S., Rosselli, M., Imthurn, B., & Spanaus, K. S. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.564684 · Cited by 8
Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
Kim, N., Yoo, H.-N., Hyun, H. S., Lee, D., Yoon, B.-K., & Choi, D. (2015) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2015.58.5.397 · Cited by 8
Effect of the injectable contraceptive depot‐medroxyprogesterone acetate on coagulation parameters in new users
Melhado‐Kimura, V., Annichino‐Bizzacchi, J. M., Quaino, S. K. P., Montalvão, S. L., Bahamondes, L. G., & Fernandes, A. M. D. S. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13306 · Cited by 8
Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users
Merki‐Feld, G. S., Epple, G., Caveng, N., Imthurn, B., Seifert, B., Sándor, P. S., & Gantenbein, A. R. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0801-7 · Cited by 8
Thrombotic risk minimization for D iane‐35 and generics
Bezemer, I. D., Smits, E., Beest, F. J. A. P., Asiimwe, A., & Herings, R. M. C. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4319 · Cited by 8
COCs containing dienogest and 30 µg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: A meta-analysis of four large cohort studies
Dinger, J. (2020) · Frontiers in Women’s Health · doi:10.15761/fwh.1000175 · Cited by 8
Implanon use lowers plasma concentrations of high-molecular-weight adiponectin
Merki‐Feld, G. S., Imthurn, B., Rosselli, M., & Spanaus, K. S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.05.018 · Cited by 8
Oral contraception in women with mild thrombophilia: What have we learned recently?
Blanco-Molina, Á. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.263 · Cited by 8
Epidemiologic Research Using Administrative Databases: Garbage In, Garbage Out
Grimes, D. A. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318209703a · Cited by 8
Commentary: Launch of a Quality Improvement Network for Evidence-Based Management of Uncommon Pediatric Endocrine Disorders: Turner Syndrome as a Prototype
Rosenfield, R. L., DiMeglio, L. A., Mauras, N., ROSS, J. L., Shaw, N. D., Greeley, S. A. W., Haymond, M. W., Rubin, K., & Rhodes, E. T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3845 · Cited by 8
Representation of women in cardiovascular disease management: a systematic analysis of ESC guidelines
Lashkarinia, S. S., Lee, A., Baptiste, T. M. G., Barrows, R. K., Sillett, C., Rodero, C., Tayal, U., de Marvao, A., Panay, N., Williamson, C., et al. (2025) · Open Heart · doi:10.1136/openhrt-2025-003320 · Cited by 10
Risques cardiovasculaires de la contraception orale estro-progestative : au-delà de la polémique…
Gronier, H., & Robin, G. (2014) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2014.01.024 · Cited by 7
Drospirenone detected in postmortem blood of a young woman with pulmonary thromboembolism: A case report and review of the literature
Idota, N., Kobayashi, M., Miyamori, D., Kakiuchi, Y., & Ikegaya, H. (2014) · Legal Medicine · doi:10.1016/j.legalmed.2014.10.001 · Cited by 7
The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N′-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet aggregation
Flores-García, M., Fernández-G, J. M., León-Martínez, M., Hernández‐Ortega, S., Pérez-Méndez, O. A., Correa‐Basurto, J., Carreón‐Torres, E., Tolentino-López, L. E., Ceballos, G. M., & de la Peña-Dı́az, A. (2012) · Steroids · doi:10.1016/j.steroids.2012.01.010 · Cited by 7
Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
Shapiro, S. (2013) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2012-100577 · Cited by 7
Ten Challenges in Contraception
Binette, A., Howatt, K., Waddington, A., & Reid, R. L. (2016) · Journal of Women s Health · doi:10.1089/jwh.2016.5854 · Cited by 7
Cerebral venous sinus thrombosis in the setting of combined vaginal contraception
Vo, T. L., Cook, R. M., Rondina, M. T., & Kaplan, D. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283658ae2 · Cited by 7
Renal vein thrombosis associated with oral contraception and smoking: a case report from Japan, with literature review
Sasaki, Y., Shimabukuro, A., Isegawa, T., Tamori, Y., Koshiishi, T., & Yonaha, H. (2013) · CEN Case Reports · doi:10.1007/s13730-013-0095-9 · Cited by 7
Maladie thromboembolique veineuse dans la région de Sidi Bel Abbes, Algérie: fréquence et facteurs de risque
Chalal, N., & Demmouche, A. E. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.16.45.2620 · Cited by 7
Risk of venous thrombosis associated with different types of combined oral contraceptive preparations
Vlieg, A. V. H., & Rosendaal, F. R. (2014) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2128 · Cited by 7
Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature
Mir, D. I., Ardabilygazir, A., Afshariyamchlou, S., & Sachmechi, I. (2018) · Cureus · doi:10.7759/cureus.2978 · Cited by 7
Gynecologic and Reproductive Considerations
Jennings, R. T., & Baker, E. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9889-0_24 · Cited by 7
A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea
Osuga, Y., Hayashi, K., & Kanda, S. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.010 · Cited by 7
Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States
Kaplan, S., Bertoia, M. L., Wang, F. T., Zhou, L., Lass, A., Evans, A., Dhanda, S., Roy, D., & Seeger, J. D. (2021) · Contraception · doi:10.1016/j.contraception.2021.09.013 · Cited by 7
Hormonal Contraception
Bruni, V., Dei, M., & Pampaloni, F. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_7 · Cited by 7
Contraception knowledge and practices among students in Lebanese universities
Tayeh, G. A., Khalil, K., Khoury, A., Maalouf, S., Mansour, F., Attieh, E., Sassine, S., Antoun, M. A., & Zakaria, H. M. (2022) · Journal of Biosocial Science · doi:10.1017/s0021932022000098 · Cited by 7
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use
Blanco-Molina, Á., Trujillo‐Santos, J., Pesavento, R., Rosa, V., Falgà-Tirado, C., Tolosa-Vilella, C., Mazzolai, L., Samperiz, A. L., Duce, R., & Monréal, M. (2017) · Thrombosis Research · doi:10.1016/s0049-3848(17)30059-2 · Cited by 7
The progestogen content of combined oral contraceptives and venous thromboembolic risk
Hannaford, P. C. (2011) · BMJ · doi:10.1136/bmj.d6592 · Cited by 7
Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review
Hostiuc, M., & Negoi, I. (2025) · Medicina · doi:10.3390/medicina61050933 · Cited by 6
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
Creinin, M. D., Angulo, A., Colli, E., & Archer, D. F. (2023) · Contraception · doi:10.1016/j.contraception.2023.110136 · Cited by 6
Evolution of Oral Contraceptive Pills
Bhalerao-Gandhi, A., & Supe, P. (2024) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-024-01988-4 · Cited by 6
Hormonal Contraception and Retinal Vascular Occlusion Risk
Niazi, S., Gnesin, F., Jawad, B. N., Niazi, Z., Løkkegaard, E., Mørch, L. S., Torp-Pedersen, C. T., Subhi, Y., & Meaidi, A. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.05.027 · Cited by 6
Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol
Kroll, R., Ackerman, R. T., Feldman, R., Howard, B. K., Weiss, H., Hsieh, J., & Ricciotti, N. A. (2015) · Contraception · doi:10.1016/j.contraception.2015.10.007 · Cited by 6
An unusual case of pulmonary embolism in a young healthy female competitive rower.
Rand, K., & Sherman, C. B. (2014) · PubMed · Cited by 6
A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives
Ademi, Z., Sutherland, C. S., van Stiphout, J., Michaud, J., Tanačković, G., & Schwenkglenks, M. M. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1554-5 · Cited by 6
Hormonal Contraceptive Agents: A Need for Pediatric-Specific Studies
Bonny, A. E., Lange, H. L. H., & Gomez‐Lobo, V. (2014) · PEDIATRICS · doi:10.1542/peds.2014-1511 · Cited by 6
Effect of information on the perception of users and prospective users of combined oral contraceptives regarding the risk of venous thromboembolism
Machado, R. B., Morimoto, M., Santana, N., Arruda, L. F., Bernardes, C. R., & de Souza, I. M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.947568 · Cited by 6
Pulmonary embolism and deep vein thrombosis related to oral contraceptive use
Kim, J., & Kim, Y. (2013) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2013.56.4.273 · Cited by 6
Navigating Hormones and Gynecologic Concerns among Female Adolescents in the Settings of Thrombophilia and Anticoagulation
Dietrich, J. E., & Srivaths, L. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.05.005 · Cited by 6
Effects of drospirenone on adhesion molecule expression and monocyte adherence in human endothelial cells
Ito, F., Mori, T., Takaoka, O., Tanaka, Y., Koshiba, A., Tatsumi, H., Iwasa, K., & Kitawaki, J. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.03.044 · Cited by 6
Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient
Hernández-Suárez, D. F., Claudio‐Campos, K., Mirabal-Arroyo, J. E., Torres-Hernández, B. A., López‐Candales, A., Melín, K., & Duconge-Soler, J. (2016) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709616682049 · Cited by 6
Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
Jang, Y.-S., Lee, E. S., & Kim, Y. (2021) · Obstetrics & Gynecology Science · doi:10.5468/ogs.20374 · Cited by 6
Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol
Jensen, J. T., Bitzer, J., & Serrani, M. (2013) · Open Access Journal of Contraception · doi:10.2147/oajc.s50693 · Cited by 6
Impact of the 2013 French Pill Crisis on Women’s Behaviour Regarding Contraception
Lemaître, M., Lastennet, G., Syr, D., Emmerich, J., & Zureik, M. (2015) · Drugs - Real World Outcomes · doi:10.1007/s40801-015-0011-z · Cited by 6
Os riscos do uso prolongado de contraceptivos hormonais
dos Santos, R. L., Barbosa, A. D. L. D. O., Santana, A. L., Farias, J. V. C., de Macêdo, P. R., & Farias, I. C. C. (2020) · Research Society and Development · doi:10.33448/rsd-v9i11.10394 · Cited by 6
Controversies in Contraception
Kiley, J. W., Armstrong, W. A., & SHULMAN, L. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-46391-5_19 · Cited by 6
Sex Hormone Supplementation and Cardiovascular Disease Risk
Kampka, Z., Balwierz, M., & Wybraniec, M. T. (2026) · Medicina · doi:10.3390/medicina62010134 · Cited by 5
Perceptions of Portuguese medical coders on the transition to ICD-10-CM/PCS: A national survey
Martins, F. S., Lopes, F., Souza, J., Freitas, A., & Santos, J. V. (2023) · Health Information Management Journal · doi:10.1177/18333583231180294 · Cited by 5
Thrombosis and thrombophilia: principles for pediatric patients
Trenor, C. C. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000388937.62364.f5 · Cited by 5
Contraception orale et risque vasculaire
Bouchard, P., Spira, A., Ville, Y. G., Conard, J., & Sitruk-Ware, R. L. (2013) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31602-4 · Cited by 5
Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information
Khialani, D., Jones, M. E., Szépligeti, S. K., Ording, A. G., Ehrenstein, V., Petersen, I., & Vlieg, A. V. H. (2020) · Contraception X · doi:10.1016/j.conx.2020.100018 · Cited by 5
Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studies
Barnett, C., Bauerfeind, A., von Stockum, S., & Heinemann, K. (2021) · AJOG Global Reports · doi:10.1016/j.xagr.2021.100041 · Cited by 5
Progestogen-only oral contraceptives
Machado, R. B., & Politano, C. A. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0042-1748754 · Cited by 5
Evaluation of Activated Protein C Resistance Using Thrombin Generation Test
Douxfils, J., Bouvy, C., & Morimont, L. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3175-1_12 · Cited by 5
An update on new orally administered contraceptives for women
Nelson, A. L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1100173 · Cited by 5
Effects of estrogens and progestagens on the primary variables of haemostasis
Ibrahimi, E., & Koni, M. (2014) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.5455/2320-1770.ijrcog20140305 · Cited by 5
Therapeutic Potential of miR-494 in Thrombosis and Other Diseases: A Review
Tay, J. W., Tiao, J. Y.-H., Hughes, Q., Gilmore, G., & Baker, R. I. (2016) · Australian Journal of Chemistry · doi:10.1071/ch16020 · Cited by 5
Severely biased review of studies assessing the risk of venous thrombosis in users of drospirenone‐containing oral contraceptives
Lidegaard, Ø. (2018) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15211 · Cited by 5
The Impact of Progestin-only Contraception on Adolescents with Macromastia
Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2021) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000003421 · Cited by 5
The Impact of Combined Oral Contraceptives on Adolescents with Macromastia
Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009513 · Cited by 5
Cerebral venous sinus thrombosis due to oral contraceptive use: Postmortem 3T-MRI and autopsy findings
Uemura, M., Tsukamoto, Y., Akaiwa, Y., Watanabe, M., Tazawa, A., Kasahara, S., Endou, M., Ogura, R., Okamoto, K., Fujii, Y., et al. (2016) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2016.01.002 · Cited by 5
Pulmonary embolism due to exogenous estrogen intoxication
Celik, C., Carus, M., & Büyükçam, F. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.07.084 · Cited by 5
Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
Ekman, J., & Skjeldestad, F. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027888 · Cited by 5
Risk Factors for Venous Thromboembolism in Women of Childbearing Age
Xu, K., & Chan, N. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2125-3290 · Cited by 5
Update in Women’s Health for the General Internist
Schwarz, E. B., McNamara, M., Miller, R. G., & Walsh, J. M. E. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1503-x · Cited by 5
Risk of venous thromboembolism with drospirenone-containing oral contraceptives
Brown, D. A., & Vartan, C. M. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100432 · Cited by 5
Controversies in Contraception
Kiley, J. W., & SHULMAN, L. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-20185-6_15 · Cited by 5
Contracepção em mulheres com condições clínicas especiais. Critérios médicos e elegibilidade
Silveira, C. O., Mendes, S. S. M., Dias, J. A., Ferreira, M. C. F., & Paiva, S. D. P. C. (2014) · Reprodução & Climatério · doi:10.1016/j.recli.2014.06.002 · Cited by 4
Harms of third- and fourth-generation combined oral contraceptives in premenopausal women: A systematic review and meta-analysis
Flores-Rodríguez, A., González-Colmenero, F. D., García-Leal, M., Sáenz-Flores, M., Burciaga-Jimenez, E., Hernández, J. A. Z., Álvarez‐Villalobos, N. A., Rodríguez-Guajardo, R., Morales-Martínez, F. A., Sordia-Hernández, L. H., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231184227 · Cited by 4
Conhecimentos dos Médicos Residentes de Ginecologia e Obstetrícia sobre Contracepção Hormonal em Situações Especiais
Giglio, M. R. P., Melo, G. P., Ferreira, V. G., Albernaz, M. A., & Ribeiro, M. O. (2017) · Revista Brasileira de Educação Médica · doi:10.1590/1981-52712015v41n1rb20160023 · Cited by 4
Progestógenos: farmacologia e uso clínico
Vigo, F. M., Lubianca, J. N., & Corleta, H. V. E. (2011) · Cited by 4
Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database
Arias, L. H. M., Sáinz-Gil, M., Navarro-García, E., Valdivieso, I. S., & Fadrique, R. S. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00282-3 · Cited by 4

Authors: Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C.
Affiliations: University of Copenhagen (DK)
Venue: BMJ
Publisher: BMJ
Published: 2009-08-13
Volume: 339
Issue: aug13 2
Pages: b2890-b2890
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.b2890
PMC: PMC2726928
OpenAlex: W2027062965
Cited by: 709
References: 29
Citations by year: 2026: 19 · 2025: 39 · 2024: 17 · 2023: 27 · 2022: 35 · 2021: 42 · 2020: 33 · 2019: 31 · 2018: 34 · 2017: 46 · 2016: 32 · 2015: 41 · 2014: 61 · 2013: 74 · 2012: 45
FWCI: 44.51
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: BMJ (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: Rigshospitalet
Topics: Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: hormonal contraception, venous thromboembolism, deep vein thrombosis, pulmonary embolism, oral contraceptives, estrogen dose, progestogens, levonorgestrel, norethisterone, desogestrel, gestodene, drospirenone, cyproterone, route of administration, duration of use, thrombosis risk
MeSH terms: Adolescent, Adult, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Denmark, Epidemiologic Methods, Female, Humans, Middle Aged, Age Distribution, Venous Thromboembolism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hormonal contraception and risk of venous thromboembolism: national follow-up study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks